Loading provider…
Loading provider…
Hematology & Oncology Physician in Coeur D Alene, ID
NPI: 1124071592Primary Practice Location
Beacon Clinic
980 W Ironwood Dr, Coeur D Alene, ID
Primary Employer
Beacon Clinic
yourbeaconclinic.com
HQ Phone
Get MD Danko's Phone Numberphone_androidMobile
Get MD Danko's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardID State Medical License
WA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 300 | 752 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 168 | 1,014 |
| 3 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 166 | 369 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 141 | 213 |
| 5 | 80053Blood test, comprehensive group of blood chemicals | 133 | 274 |
Authors: Guy Jones, Jonathan Tward, Benjamin Arthurs, Wayne Lamoreaux, Irfan Jawed, Anand Shivnani
Journal: Am J Clin Oncol
Authors: Kevin Weeks, Hakan Kaya, Christopher Lee, Wayne Lamoreaux, Irfan Jawed
Journal: Int J Hematol
Publication Date: 2011-12-09
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer.
Authors: Mark Fleming, William Berry, Steven Rousey, Tomasz Beer
Publication Date: 2011-09-23
Lead Sponsor: G1 Therapeutics, Inc.
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Gemcitabine, DRUG: Avelumab, DRUG: Trilaciclib
Lead Sponsor: Gradalis, Inc.
Intervention / Treatment: DRUG: Nivolumab, BIOLOGICAL: Vigil™
Lead Sponsor: Merrimack Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Gemcitabine, DRUG: Nab-Paclitaxel, DRUG: MM-141